O

OrbiMed Portfolio holdings

AUM $4.59B
1-Year Est. Return 131.45%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+131.45%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.17B
AUM Growth
+$193M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
120
New
Increased
Reduced
Closed

Top Buys

1
+$52.4M
2
+$48.2M
3
+$38.6M
4
ASND icon
Ascendis Pharma A/S
ASND
+$29.4M
5
ORIC icon
Oric Pharmaceuticals
ORIC
+$28.9M

Top Sells

1
+$105M
2
+$93.6M
3
+$81.8M
4
BSX icon
Boston Scientific
BSX
+$39.8M
5
CYTK icon
Cytokinetics
CYTK
+$35.6M

Sector Composition

1 Healthcare 99.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$252M 6.04%
15,518,492
2
$237M 5.69%
2,429,300
-383,900
3
$230M 5.51%
301,200
-36,400
4
$184M 4.42%
2,718,735
5
$163M 3.91%
7,959,538
6
$138M 3.3%
301,600
-40,300
7
$133M 3.18%
359,200
8
$131M 3.14%
1,684,000
-24,000
9
$128M 3.08%
287,200
-3,800
10
$127M 3.05%
172,300
-35,700
11
$109M 2.61%
3,704,959
12
$107M 2.57%
5,693,589
13
$93.5M 2.24%
1,415,020
14
$91.8M 2.2%
3,034,858
15
$83.3M 2%
8,288,510
16
$71.4M 1.71%
1,638,886
-174,000
17
$70.1M 1.68%
4,002,887
18
$69.6M 1.67%
1,726,850
-151,000
19
$69.1M 1.66%
429,300
-164,134
20
$64.6M 1.55%
531,800
+103,900
21
$56.8M 1.36%
7,562,971
22
$55.9M 1.34%
3,027,328
23
$55.7M 1.34%
1,469,494
+709,143
24
$54.4M 1.31%
994,616
+387,300
25
$53.3M 1.28%
15,219,994
1
2 3 4 5